Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Laura M Wanner"'
Autor:
Erkan Kiris, Jonathan E Nuss, Stephanie M Stanford, Laura M Wanner, Lisa Cazares, Michael F Maestre, Hao T Du, Glenn Y Gomba, James C Burnett, Rick Gussio, Nunzio Bottini, Rekha G Panchal, Christopher D Kane, Lino Tessarollo, Sina Bavari
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0129264 (2015)
There is an urgent need to develop novel treatments to counter Botulinum neurotoxin (BoNT) poisoning. Currently, the majority of BoNT drug development efforts focus on directly inhibiting the proteolytic components of BoNT, i.e. light chains (LC). Al
Externí odkaz:
https://doaj.org/article/60298f029db949189b12f9558abf609f
Autor:
Jonathan E Nuss, Kylene Kehn-Hall, Ashwini Benedict, Julie Costantino, Michael Ward, Brian D Peyser, Cary J Retterer, Lyal E Tressler, Laura M Wanner, Hugh F McGovern, Anum Zaidi, Scott M Anthony, Krishna P Kota, Sina Bavari, Ramin M Hakami
Publikováno v:
PLoS ONE, Vol 9, Iss 5, p e93483 (2014)
Rift Valley fever is a potentially fatal disease of humans and domestic animals caused by Rift Valley fever virus (RVFV). Infection with RVFV in ruminants can cause near 100% abortion rates and recent outbreaks in naïve human populations have sugges
Externí odkaz:
https://doaj.org/article/c96143c0a8d945fcb90fafb7f6419a2f
Autor:
Sina Bavari, Cary J. Retterer, Edna Torres-Melendez, Sarah J. Sandwick, Laura M. Wanner, Lyal E. Tressler, Jonathan E. Nuss, Gordon Ruthel, James C. Burnett
Publikováno v:
Toxins, Vol 3, Iss 3, Pp 207-217 (2011)
Botulinum neurotoxins (BoNTs) comprise seven distinct serotypes that inhibit the release of neurotransmitter across neuromuscular junctions, resulting in potentially fatal flaccid paralysis. BoNT serotype A (BoNT/A), which targets synaptosomal-associ
Externí odkaz:
https://doaj.org/article/9870667b3dd6453db0a5f49a6ad142f7
Autor:
Lino Tessarollo, Krishna P. Kota, James C. Burnett, Hao T. Du, Rekha G. Panchal, Jonathan E. Nuss, Brian D. Peyser, Laura M. Wanner, Glenn Y. Gomba, Erkan Kiris, Rick Gussio, Christopher D. Kane, Sina Bavari
Publikováno v:
Neurotoxicity Research. 27:384-398
Botulinum neurotoxins (BoNTs), the causative agents of botulism, are potent inhibitors of neurotransmitter release from motor neurons. There are currently no drugs to treat BoNT intoxication after the onset of the disease symptoms. In this study, we
Publikováno v:
SLAS Discovery. 15:928-936
Botulism, the disease caused by botulinum neurotoxins (BoNTs), secreted by the spore-forming, anaerobic bacteria Clostridium botulinum, has been associated with food poisoning for centuries. In addition, the potency of BoNTs coupled with the current
Autor:
Glenn Y. Gomba, Rick Gussio, James C. Burnett, Sina Bavari, Christopher D. Kane, Michael F. Maestre, Jonathan E. Nuss, Stephanie M. Stanford, Lisa H. Cazares, Lino Tessarollo, Nunzio Bottini, Hao T. Du, Rekha G. Panchal, Laura M. Wanner, Erkan Kiris
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0129264 (2015)
PLoS ONE
PLoS ONE
There is an urgent need to develop novel treatments to counter Botulinum neurotoxin (BoNT) poisoning. Currently, the majority of BoNT drug development efforts focus on directly inhibiting the proteolytic components of BoNT, i.e. light chains (LC). Al
Autor:
Glenn Y. Gomba, Veronica Soloveva, Rekha G. Panchal, Christopher D. Kane, Laura M. Wanner, Krishna P. Kota, Erkan Kiris, Sina Bavari
Publikováno v:
Journal of Visualized Experiments.
Synaptosomal-associated protein-25 (SNAP-25) is a component of the soluble NSF attachment protein receptor (SNARE) complex that is essential for synaptic neurotransmitter release. Botulinum neurotoxin serotype A (BoNT/A) is a zinc metalloprotease tha
Autor:
Gordon Ruthel, Michelle M. Butler, Laura M. Wanner, Sina Bavari, Jonathan E. Nuss, Norton P. Peet, Steven C. Cardinale, Ramdas Pai, Terry L. Bowlin, Bing Li
Publikováno v:
The botulinum journal. 2(1)
Botulinum Neurotoxins (BoNTs) are used therapeutically and in cosmetics, providing potential for bioterrorist activity, thus driving the search for small-molecule BoNT inhibitors. This report describes a 70,000-compound screen for inhibition of BoNT/
Autor:
Krishna P. Kota, Lino Tessarollo, Dawn C. I. Koh, Sina Bavari, Rick Gussio, Jonathan E. Nuss, Edna Torres-Melendez, James C. Burnett, Erkan Kiris, Laura M. Wanner
Botulinum neurotoxins (BoNTs) inhibit cholinergic synaptic transmission by specifically cleaving proteins that are crucial for neurotransmitter exocytosis. Due to the lethality of these toxins, there are elevated concerns regarding their possible use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e6e01f0fe5e67d40a493bd1f266d94e
https://europepmc.org/articles/PMC3081902/
https://europepmc.org/articles/PMC3081902/
Autor:
Rick Gussio, Richard J. Sciotti, Donatella Taramelli, James C. Burnett, Charlotte A. Lanteri, Dejan Opsenica, Nicoletta Basilico, Igor Opsenica, Nina M. Todorović, Montip Gettayacamin, Laura M. Wanner, Sina Bavari, Jonathan E. Nuss, Bogdan A. Šolaja, Rekha G. Panchal
Publikováno v:
Journal of Medicinal Chemistry
A 1,7-bis(alkylamino)diazachrysene-based small molecule was previously identified as an inhibitor of the botulinum neurotoxin serotype A light chain metalloprotease. Subsequently, a variety of derivatives of this chemotype were synthesized to develop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::031f4c5a7188b288ac83f061e5b994c1
https://cer.ihtm.bg.ac.rs/handle/123456789/901
https://cer.ihtm.bg.ac.rs/handle/123456789/901